[Treatment of experimental immune complex nephritis with indomethacin]. 1979

I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch

Functional, histological and immune-histological examination were performed in altogether 64 Wistar-rats, in order to control the effect of a therapy with 2 mg/kg per body weight indomethazine lasting 2 months at the model of an experimental immune complex nephritis. In 44 rats after presensibilisation an immune complex nephritis was performed by intraperitoneal injections with human serum albumin which were repeated three times a week. 24 glomerulonephritis animals and other 20 animals without glomerulonephritis were daily administered indomethazin through a tube probe, the remaining 20 animals with glomerulonephritis served as untreated control groups. The excretion function of the kidney was tested before the beginning of the experiment, 2 weeks after the beginning of the therapy and the regular serum injections, respectively, and before the end of the experiment by determination of the biological half-life period of 131J-hippuran. In every case one day before this the proteinuria during 24 hours was determined. At the end of the experiment the kidneys were examined histologically and immune-histologically. The results showed that indomethazin does not lead to a clear influence on the proteinuria in the immune complex nephritis of the rat. The excretion of 131J-hippuran was significantly restricted, whereas the histological and immune-histological preparations in the animals with foreign serum injections showed clear changes of the glomeruli in the sense of an early stage of the immune complex nephritis, however, they did not show any essential influence by indomethazin. That is, indomethazin had altogether no favourable effect on the immune complex nephritis of the rat.

UI MeSH Term Description Entries
D007105 Immune Complex Diseases Group of diseases mediated by the deposition of large soluble complexes of antigen and antibody with resultant damage to tissue. Besides SERUM SICKNESS and the ARTHUS REACTION, evidence supports a pathogenic role for immune complexes in many other IMMUNE SYSTEM DISEASES including GLOMERULONEPHRITIS, systemic lupus erythematosus (LUPUS ERYTHEMATOSUS, SYSTEMIC) and POLYARTERITIS NODOSA. Hypersensitivity, Type III,Type III Hypersensitivity,Disease, Immune Complex,Diseases, Immune Complex,Hypersensitivities, Type III,Immune Complex Disease,Type III Hypersensitivities
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D008297 Male Males
D005921 Glomerulonephritis Inflammation of the renal glomeruli (KIDNEY GLOMERULUS) that can be classified by the type of glomerular injuries including antibody deposition, complement activation, cellular proliferation, and glomerulosclerosis. These structural and functional abnormalities usually lead to HEMATURIA; PROTEINURIA; HYPERTENSION; and RENAL INSUFFICIENCY. Bright Disease,Kidney Scarring,Glomerulonephritides,Scarring, Kidney
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
September 1970, Saishin igaku. Modern medicine,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
December 1975, JPMA. The Journal of the Pakistan Medical Association,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
September 1991, Clinical immunology and immunopathology,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
June 1982, Nihon Jinzo Gakkai shi,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
November 1976, Lakartidningen,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
May 1994, Kidney international,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
January 1990, Nephron,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
August 1977, Clinical and experimental immunology,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
April 1980, Orvosi hetilap,
I Hagemann, and W Schneider, and H Philipp, and D Strangfeld, and H Siewert, and G Tietze, and R Pietsch
April 1982, The New England journal of medicine,
Copied contents to your clipboard!